| Richard Cullen Hopkins, MD | |
|
7620 Wallace Blvd, Amarillo, TX 79124-2154 | |
| (806) 359-5468 | |
| (806) 359-7201 |
| Full Name | Richard Cullen Hopkins |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 7620 Wallace Blvd, Amarillo, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174552723 | NPI | - | NPPES |
| 181727201 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | M3586 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist St Anthony's Hospital | Amarillo, TX | Hospital |
| Northwest Texas Hospital | Amarillo, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Panhandle Obstetrics And Gynecology | 7810993391 | 7 |
News Archive
A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency room was safe and effective, ruling out heart attack in emergency room patients faster than a conventional method, according to new research in the American Heart Association's journal Circulation.
Two researchers from Radboud University and one from Radboudumc are to receive a Starting Grant of 1.5 million Euros from the European Research Council (ERC). This grant is awarded to talented young scientists, giving them the opportunity to form their own research group. Furthermore, astrophysicist Heino Falcke will receive an ERC Proof of Concept Grant.
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
QLT Inc. ("QLT" or the "Company") today announced that its board of directors has authorized the repurchase of up to 5% of QLT's outstanding common shares ("Common Shares") over the next 12 months on the NASDAQ Stock Market ("NASDAQ") and the Toronto Stock Exchange ("TSX"), pending required approvals.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its subsidiary, Biospherics Incorporated, has been awarded $469,479 under HR: 3590 – Patient Protection and Affordable Care Act in immediately available funds.
› Verified 1 days ago
| Entity Name | Panhandle Obstetrics & Gynecology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942215488 PECOS PAC ID: 7810993391 Enrollment ID: O20061005000329 |
News Archive
A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency room was safe and effective, ruling out heart attack in emergency room patients faster than a conventional method, according to new research in the American Heart Association's journal Circulation.
Two researchers from Radboud University and one from Radboudumc are to receive a Starting Grant of 1.5 million Euros from the European Research Council (ERC). This grant is awarded to talented young scientists, giving them the opportunity to form their own research group. Furthermore, astrophysicist Heino Falcke will receive an ERC Proof of Concept Grant.
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
QLT Inc. ("QLT" or the "Company") today announced that its board of directors has authorized the repurchase of up to 5% of QLT's outstanding common shares ("Common Shares") over the next 12 months on the NASDAQ Stock Market ("NASDAQ") and the Toronto Stock Exchange ("TSX"), pending required approvals.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its subsidiary, Biospherics Incorporated, has been awarded $469,479 under HR: 3590 – Patient Protection and Affordable Care Act in immediately available funds.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Cullen Hopkins, MD 7620 Wallace Blvd, Amarillo, TX 79124-2154 Ph: (806) 359-5468 | Richard Cullen Hopkins, MD 7620 Wallace Blvd, Amarillo, TX 79124-2154 Ph: (806) 359-5468 |
News Archive
A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency room was safe and effective, ruling out heart attack in emergency room patients faster than a conventional method, according to new research in the American Heart Association's journal Circulation.
Two researchers from Radboud University and one from Radboudumc are to receive a Starting Grant of 1.5 million Euros from the European Research Council (ERC). This grant is awarded to talented young scientists, giving them the opportunity to form their own research group. Furthermore, astrophysicist Heino Falcke will receive an ERC Proof of Concept Grant.
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
QLT Inc. ("QLT" or the "Company") today announced that its board of directors has authorized the repurchase of up to 5% of QLT's outstanding common shares ("Common Shares") over the next 12 months on the NASDAQ Stock Market ("NASDAQ") and the Toronto Stock Exchange ("TSX"), pending required approvals.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its subsidiary, Biospherics Incorporated, has been awarded $469,479 under HR: 3590 – Patient Protection and Affordable Care Act in immediately available funds.
› Verified 1 days ago
Teresa Baker, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-414-9650 Fax: 806-354-5730 | |
Brandon Michael Haney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-414-9001 | |
Londa G Carrasco, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1911 Port Ln Ste 2, Amarillo, TX 79106 Phone: 806-359-9100 Fax: 806-359-7022 | |
Pablo R. Diaz-esquivel, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1600 Coulter, Building E Suite 703, Amarillo, TX 79106 Phone: 806-355-9257 Fax: 806-353-9871 | |
Dr. Estelle Archer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1900 S Coulter St Ste B, Amarillo, TX 79106 Phone: 806-350-7312 Fax: 806-356-0045 | |
Amanda Dawn Murdock, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1301 S Coulter St, Suite 300, Amarillo, TX 79106 Phone: 806-355-6330 Fax: 806-351-0950 |